Although the US dominates nanotechnology patent publications in terms of quantity, patents from some other countries may have a similar or even higher average impact on the field of nanotechnology.

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

announces today a patent publication by the Instituto Mexicano de la Propriedad Industrial (IMPI), the National Mexico Patent Office. The patent refers to the Company’s innovative combination ...

Clearmind Medicine (CMND) announced a patent publication by the Instituto Mexicano de la Propriedad Industrial, the National Mexico Patent Office. The patent refers to the Company’s combination ...

(Nasdaq: CMND), (FSE: CWY0) ("Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated ...

Clearmind Medicine Inc., a Vancouver-based biotech company specializing in psychedelic-derived therapeutics, announced the publication of a new patent by Mexico's National Patent Office.

The Patent Eligibility Restoration Act (PERA) proposes a solution to a complex debate: What can be patented, and when do nature and thoughts become property? This article provides an overview of the ...

Clearmind has announced the publication of a patent application in Mexico for the innovative combination of 3,4-Methylenedioxymethamphetamine (MDMA) with N-Acylethanolamines. The patent refers to ...